Basic information Safety Related Supplier

ChemicalBook Product Catalog Biochemical Engineering Biochemical Reagents Agonist Inhibitors Akt1 and Akt2-IN-1

1/1

Akt1 and Akt2-IN-1 NEW

Get Latest Price

Min. Order
Purity
Cas No893422-47-4
Supply Ability10g
Update time2026-04-16

TargetMol Chemicals Inc.

TargetMol Chemicals Inc.

VIP4Y

United States

United States

show more

Enterprise Verified

Business Bank account Basic Contact Infomation Business Address Trade Company

Chemical Properties

Product Name	Akt1 and Akt2-IN-1
CAS No	893422-47-4
EC-No
Min. Order
Purity
Supply Ability	10g
Release date	2026/04/16

Product Introduction

Bioactivity

Name	Akt1 and Akt2-IN-1
Description	Akt1 and Akt2-IN-1 is an allosteric inhibitor of Akt1 (IC50=3.5 nM) and Akt2 (IC50=42 nM). It has potent and balanced activity.
In vitro	Akt1 and Akt2-IN-1 (Compound 17) has moderate activity in an hERG binding assay (IC50=5610 nM) and is a substrate for human P-glycoprotein[1]. Consistent with the allosteric mode of inhibition, Akt1 and Akt2-IN-1 (Compound 17) is dependent on the PH-domain for Akt inhibition. Akt1 and Akt2-IN-1 (Compound 17) is selective for Akt1/2 over Akt3 (IC50=1900 nM), and is highly selective over other members of the AGC family of kinases (>50 μM vs PKA, PKC, SGK).
In vivo	Akt1 and Akt2-IN-1 (Compound 17) is well tolerated in at exposures that provide high levels of Akt1 and 2 inhibition in vivo. Akt1 and Akt2-IN-1 (Compound 17) shows good pharmacokinetics in rat with a low clearance of 4.6 mL/min/kg and a half-life of 3.8 h. Due to the improved cell potency, physical properties, and rodent pharmacokinetics of Akt1 and Akt2-IN-1 (Compound 17), tolerability and Akt inhibition are assessed in mice. Akt1 and Akt2-IN-1 (Compound 17) has also been shown to inhibit the growth of A2780 tumors in vivo when used as monotherapy and has potent inhibitory activity against Akt1 and 2 in vivo in a mouse lung and efficacy in a tumor xenograft model. Using an acute dosing schedule (IP dosing of 50 mg/kg at times 0, 3, and 8 h), administration of Akt1 and Akt2-IN-1 (Compound 17) is well tolerated in mice and shows high levels of Akt inhibition in mouse lung[1].
Storage	store at low temperature \| Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice/Shipping at ambient temperature.
Solubility Information	DMSO : 35 mg/mL (64.86 mM), Sonication is recommended.
Keywords	Akt2 \| Akt1 and Akt2-IN-1 \| Akt-1 and Akt2-IN-1 \| Akt1 and Akt2IN1 \| Akt1 and Akt2 IN 1 \| Akt1
Inhibitors Related	Aceglutamide \| Musk ketone \| Stearamide \| Bisphenol A \| Creatine monohydrate \| Hyaluronic acid \| Ethyl linoleate \| Artemisinin \| L-Valine \| Methyl eugenol \| Chloramphenicol \| 2,3-Butanediol

show more

Company Profile Introduction

You may like

Recommended supplier

Send Inquriy